|
|
Volumn 10, Issue 5, 2015, Pages e29-e31
|
|
MET mutation associated with responsiveness to crizotinib
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CRIZOTINIB;
PEMETREXED;
SCATTER FACTOR RECEPTOR;
ANTINEOPLASTIC AGENT;
MET PROTEIN, HUMAN;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
AGED;
BONE LESION;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CASE REPORT;
CAUCASIAN;
CHROMOSOME 7;
COMPUTER ASSISTED TOMOGRAPHY;
COMPUTER MODEL;
EXON;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE DOSAGE;
HUMAN;
LETTER;
LUNG ADENOCARCINOMA;
LUNG BIOPSY;
LUNG HILUS;
LUNG LESION;
LUNG METASTASIS;
LUNG NODULE;
LYMPHADENOPATHY;
MALE;
MISSENSE MUTATION;
MULTIPLE CYCLE TREATMENT;
NEXT GENERATION SEQUENCING;
OSTEOSCLEROSIS;
PHARMACOGENETICS;
PRIORITY JOURNAL;
RADIATION DOSE;
SINGLE NUCLEOTIDE POLYMORPHISM;
SMOKING;
TREATMENT RESPONSE;
TUMOR BIOPSY;
ADENOCARCINOMA;
GENETICS;
LUNG NEOPLASMS;
MUTATION;
RETREATMENT;
ADENOCARCINOMA;
AGED;
ANTINEOPLASTIC AGENTS;
HUMANS;
LUNG NEOPLASMS;
MALE;
MUTATION;
PROTO-ONCOGENE PROTEINS C-MET;
PYRAZOLES;
PYRIDINES;
RETREATMENT;
|
|
EID: 84938222817
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0000000000000478 Document Type: Letter |
|
Times cited : (80)
|
|
References (5)
|
